Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF -mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial-Reference-Cited by-同舟云学术

Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF -mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial

Published:2018-05 Issue:5 Volume:19 Page:603-615
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Dummer Reinhard,Ascierto Paolo A,Gogas Helen J,Arance Ana,Mandala Mario,Liszkay Gabriella,Garbe Claus,Schadendorf Dirk,Krajsova Ivana,Gutzmer Ralf,Chiarion-Sileni Vanna,Dutriaux Caroline,de Groot Jan Willem B,Yamazaki Naoya,Loquai Carmen,Moutouh-de Parseval Laure A,Pickard Michael D,Sandor Victor,Robert Caroline,Flaherty Keith T

Publisher

Elsevier BV

Subject

Oncology

Reference31 articles.

1. Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas;Krauthammer;Nat Genet,2015

2. BRAF mutation predicts sensitivity to MEK inhibition;Solit;Nature,2006

3. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N Engl J Med,2011

4. Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity;Tsai;Proc Natl Acad Sci USA,2008

5. Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial;Hauschild;Lancet,2012

Cited by 805 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Malignant Pleural Effusion: A Multidisciplinary Approach;Open Respiratory Archives;2024-10

2. Neoadjuvant therapy for melanoma: past, present, and future;Surgical Oncology;2024-10

3. Exploring the multifaceted effects of silymarin on melanoma: Focusing on the role of lipid-based nanocarriers;Journal of Drug Delivery Science and Technology;2024-09

4. Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study;ESMO Open;2024-09

5. Design, Synthesis, and Biological Evaluation of 5-Amino-4-fluoro-1H-benzo[d]imidazole-6-carboxamide Derivatives as Novel and Potential MEK/RAF Complex Inhibitors Based on the “Clamp” Strategy;Journal of Medicinal Chemistry;2024-08-21